Chat with us, powered by LiveChatHorizon 2020: ERANET TRANSCAN 3- Next generation cancer immunotherapy: targeting the tumour microenvironment - FASI
FASI - Funding Aid Strategies Investments

Horizon 2020: ERANET TRANSCAN 3- Next generation cancer immunotherapy: targeting the tumour microenvironment

12 aprile 2021
DATA APERTURA
20/04/2021
SCADENZA
29/06/2021

Joint Transnational Call for Proposals 2021 (JTC 2021) co-funded by the European Commission/DG Research and Innovation on "Next generation cancer immunotherapy: targeting the tumour microenvironment", within the project "TRANSCAN-3 ERA-NET: Sustained collaboration of national and regional programmes in cancer research".

Update: Ammissione alle agevolazioni del progetto di cooperazione internazionale «Immoscan» - Decreto del 15.03.2023 - GURI 103 del 04.05.2023


;